The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Xatger 10mg prolonged release tablets

McDermott Laboratories Ltd., T/A Gerard LaboratoriesPA0577/079/002

Main Information

Trade NameXatger 10mg prolonged release tablets
Dosage FormProlonged-release tablet
Licence HolderMcDermott Laboratories Ltd., T/A Gerard Laboratories
Licence NumberPA0577/079/002

Group Information

ATC CodeG04CA Alpha-adrenoreceptor antagonists
G04CA01 alfuzosin


Licence Issued13/10/2006
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusMarketed


Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back